跳至主要内容
临床试验/ACTRN12616001224415
ACTRN12616001224415尚未招募4 期

A randomised, double-blind placebo controlled clinical trial, will be carried out to evaluate the effect of aspirin and a probiotic on the immune system, upper gut function and gastrointestinal symptoms in controls without functional dyspepsia and patients with functional dyspepsia whether treatment improves FD symptoms.

niversity of Queensland,0 个研究点目标入组 180 人开始时间: 2016年9月5日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • Dyspepsia patients: We will study 90 consecutive patients with the diagnosis of FD according to Rome III criteria after a comprehensive negative diagnostic work-up.In order to avoid variability due to the menstrual cycle, all pre-menopausal females will be tested in the first phase of the menstrual cycle. All subjects will be H. pylori negative.
  • b) Controls: we will recruit 90 age and gender matched controls without GI symptoms undergoing endoscopy for assessment of iron deficiency with a normal upper endoscopy.
  • In order to avoid variability due to the menstrual cycle, all pre-menopausal females will be tested in the first phase of the menstrual cycle. All subjects will be H. pylori negative.

排除标准

  • H. pylori positive

研究者

发起方
niversity of Queensland,

相似试验